建業新生活(9983.HK)大漲近9% 與惠每華康簽訂協議擬在醫療大健康服務等領域合作
格隆匯8月27日丨建業新生活(9983.HK)今日大漲,現漲8.81%報11.12港元,暫成交7577萬港元,最新總市值138億港元。公司今日稱已於8月26日與惠每華康簽訂戰略合作框架協議。此次簽約,雙方擬在醫療大健康服務領域深入合作,將惠每華康的產業資源與建業新生活相關平台業務結合。惠每華康負責醫療資源協調、醫療服務提供、平台嫁接與管理等;建業新生活負責客户開發、物理空間提供、平台維護等。雙方發揮各自產業與資源優勢共同管理運營相關服務平台及客户服務,以期實現資源的最優化配置。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.